Wasn't Peter also trumpeting a potential bidder for the company not so long ago? I wonder whatever happened with that?
"The Company expects combined group revenue for FY12 for all current projects to be approximately $27M with EBITDA of $14M."
"The company now expects combined FY12 group received on its current deployed projects to be approximately $21.2M ... the company expects EBITDA for FY12 to be approximately $3.3M."
Not to mention their cash position has deteriorated further to $4.3M ($6.5M previous update).
They bought Trustdefender for $15 MILLION only to sell a year later for $0.6 million... Just to recoup the millions lost in that single transaction, it would take, based on predicted EBITDA, 5 years of work to undo that loss.
Yo Peter, want to work for free for the next 5 years?
I wonder what operational expenses refers too?
This forecast does not take into account provision, if any? relating to intangible assets? ... oh, oh the Trustdefender writedown was not enough, there's more.
- Forums
- ASX - By Stock
- NBS
- Ann: Market Update
Ann: Market Update , page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NBS (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online